Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato Maserati

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 1, 2010
Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjectsSerena Delbue, Sara Tremolada, Francesca Elia, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 2002
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patientsDaria Trabattoni, Sergio Lo Caputo, Mara Biasin, et al.
Clinical Immunology (Orlando, Fla.)|October 22, 2008
Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseasesMarina Saresella, Ivana Marventano, Franca Rosa Guerini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individualsSandra A Calarota, Andrea Foli, Renato Maserati, et al.
Current HIV Research|May 17, 2007
Effects of structured treatment interruptions on metabolic, anthropometric, immunologic, and quality of life outcomes in HIV-positive adults on HAARTRenato Maserati, Andrea Foli, Lina Tomasoni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2007
Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathyFranca R Guerini, Serena Delbue, Milena Zanzottera, et al.
The New Microbiologica|August 6, 2013
Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir-containing regimensAntonella Castagna, Laura Galli, Nicola Gianotti, et al.
Current HIV Research|February 19, 2010
Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3Elena Seminari, Carmine Tinelli, Giovanni Ravasi, et al.
Infection and Drug Resistance|August 3, 2019
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinationsStefania Paolucci, Federica Novazzi, Antonio Piralla, et al.
AIDS (London, England)|April 3, 2004
Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individualsDaria Trabattoni, Stefania Piconi, Mara Biasin, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 1, 2010
Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjectsSerena Delbue, Sara Tremolada, Francesca Elia, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 2002
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patientsDaria Trabattoni, Sergio Lo Caputo, Mara Biasin, et al.
Clinical Immunology (Orlando, Fla.)|October 22, 2008
Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseasesMarina Saresella, Ivana Marventano, Franca Rosa Guerini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individualsSandra A Calarota, Andrea Foli, Renato Maserati, et al.
Current HIV Research|May 17, 2007
Effects of structured treatment interruptions on metabolic, anthropometric, immunologic, and quality of life outcomes in HIV-positive adults on HAARTRenato Maserati, Andrea Foli, Lina Tomasoni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2007
Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathyFranca R Guerini, Serena Delbue, Milena Zanzottera, et al.
The New Microbiologica|August 6, 2013
Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir-containing regimensAntonella Castagna, Laura Galli, Nicola Gianotti, et al.
Current HIV Research|February 19, 2010
Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3Elena Seminari, Carmine Tinelli, Giovanni Ravasi, et al.
Infection and Drug Resistance|August 3, 2019
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinationsStefania Paolucci, Federica Novazzi, Antonio Piralla, et al.
AIDS (London, England)|April 3, 2004
Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individualsDaria Trabattoni, Stefania Piconi, Mara Biasin, et al.
Pageof 8